Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
Open Access
- 1 June 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (6) , 525-529
- https://doi.org/10.1023/a:1008207731111
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinomaCancer, 1992
- A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinomaCancer, 1991
- Etoposideversus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trialCancer, 1990
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer GroupCancer Chemotherapy and Pharmacology, 1990
- Chemotherapy of Advanced Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1989
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986